Literature DB >> 19751456

The role of chlorthalidone in patients with high-risk hypertension.

Bertram Pitt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19751456      PMCID： PMC8673294          DOI： 10.1111/j.1751-7176.2009.00166.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  9 in total

1.  New-onset diabetes, antihypertensive treatment, and outcome.

Authors:  Paolo Verdecchia; Fabio Angeli; Gianpaolo Reboldi
Journal:  Hypertension       Date:  2007-08-06       Impact factor: 10.190

2.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

3.  Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

Authors:  Barry R Davis; Linda B Piller; Jeffrey A Cutler; Curt Furberg; Kay Dunn; Stanley Franklin; David Goff; Frans Leenen; Syed Mohiuddin; Vasilios Papademetriou; Michael Proschan; Allan Ellsworth; John Golden; Pedro Colon; Richard Crow
Journal:  Circulation       Date:  2006-05-01       Impact factor: 29.690

4.  Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: the mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study.

Authors:  Jan W Eriksson; Per-Anders Jansson; Bo Carlberg; Anders Hägg; Lisa Kurland; Maria K Svensson; Håkan Ahlström; Conny Ström; Lars Lönn; Kristina Ojbrandt; Lars Johansson; Lars Lind
Journal:  Hypertension       Date:  2008-11-03       Impact factor: 10.190

5.  Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.

Authors:  Kenneth Jamerson; Michael A Weber; George L Bakris; Björn Dahlöf; Bertram Pitt; Victor Shi; Allen Hester; Jitendra Gupte; Marjorie Gatlin; Eric J Velazquez
Journal:  N Engl J Med       Date:  2008-12-04       Impact factor: 91.245

6.  Adverse renal effects of hydrochlorothiazide in rats with myocardial infarction treated with an ACE inhibitor.

Authors:  Bart Westendorp; Inge Hamming; Mariusz K Szymanski; Gerjan Navis; Harry van Goor; Hendrik Buikema; Wiek H van Gilst; Regien G Schoemaker
Journal:  Eur J Pharmacol       Date:  2008-12-03       Impact factor: 4.432

7.  Heart failure in ALLHAT: did blood pressure medication at study entry influence outcome?

Authors:  Richard H Grimm; Barry R Davis; Linda B Piller; Jeffrey A Cutler; Karen L Margolis; Joshua Barzilay; Richard A Dart; James F Graumlich; Robert A Murden; Otelio S Randall
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-09       Impact factor: 3.738

Review 8.  Vascular protective effects of ACE inhibitors and calcium antagonists: theoretical basis for a combination therapy in hypertension and other cardiovascular diseases.

Authors:  T F Lüscher; R R Wenzel; P Moreau; H Takase
Journal:  Cardiovasc Drugs Ther       Date:  1995-08       Impact factor: 3.727

9.  Thiazide diuretics, endothelial function, and vascular oxidative stress.

Authors:  Ming-Sheng Zhou; Ivonne Hernandez Schulman; Edgar A Jaimes; Leopoldo Raij
Journal:  J Hypertens       Date:  2008-03       Impact factor: 4.844
  9 in total
  1 in total

Review 1.  Current challenges in the clinical management of hypertension.

Authors:  Luis M Ruilope
Journal:  Nat Rev Cardiol       Date:  2011-10-25       Impact factor: 32.419
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.